Technology & Innovation

SHERIDAN, WYOMING - April 4, 2026 - Research teams and organizations working on animal feed and flour milling innovation now have a structured path to external financing through the Victam Foundation's 2026 Call for Funding, with final project selections and award decisions scheduled for completion by early June 2026 at Victam International in Utrecht, The Netherlands.

Funding cycle overview

The Victam Foundation opened its 2026 Call for Funding submission window on September 12, 2025, accepting project proposals through January 31, 2026. The call targets researchers, organizations, and innovators developing projects that advance the animal feed and flour milling industries. There are no submission fees, and proposals must be submitted via the foundation's online requesting form. Applications must include a detailed project description and an expected budget; the foundation reserves the right to request additional documentation where necessary.

SHERIDAN, WYOMING - March 31, 2026 - European hospitals evaluating 2026 imaging, intervention, and workforce plans now have a new validation pathway for AI-assisted neurovascular and oncology procedures as the SHERPA consortium starts seven clinical studies focused on workflow automation, precision support, and staff-pressure reduction in minimally invasive care. The four-year project has a total budget of EUR 21.5 million, is coordinated by Philips, and is co-funded by the EU Innovative Health Initiative and industry partners. Its work targets minimally invasive treatment workflows for brain aneurysms, liver tumors, and lung biopsy settings where specialized expertise is limited and procedure complexity is high.

SHERIDAN, WYOMING - March 13, 2026 - Roche has reported positive Phase II results for petrelintide, an amylin analog being developed for people living with overweight and obesity. According to the company, petrelintide delivered up to 10.7% mean body weight reduction at week 42 compared with 1.7% for placebo, with a p-value of less than 0.001. Roche also said the maximally effective dose showed placebo-like tolerability, with no vomiting cases and no treatment discontinuations due to gastrointestinal adverse events. For the obesity treatment market, the update is relevant because efficacy and tolerability remain central to prescribing, adherence and competitive positioning.

SHERIDAN, WYOMING - December 30, 2025 - CPGIO says it has expanded its digital retail footprint by launching on multiple major marketplaces, positioning the company to support consumer brands with broader omnichannel distribution across a mix of mass, specialty, and B2B wholesale platforms.

Multi-marketplace expansion and timing

The company reported successful launches across Nordstrom, Chewy, Lowe's, Faire, and Best Buy, with the rollout beginning in November 2025. For consumer brands, the announcement signals a continued push toward diversified third-party marketplace presence as a growth lever, particularly as retailers extend marketplace models beyond core categories. For service providers and operators, the business impact typically centers on onboarding speed, catalog and content compliance, inventory synchronization, and the ability to manage pricing and pack-out strategy consistently across channels.

SHERIDAN, WYOMING - December 30, 2025 - ALS Northwest says it increased its financial investment in ALS research throughout 2025, expanding support for new approaches in treatment, prevention, and scientific understanding while joining a multi-organization funding initiative intended to strengthen the overall research pipeline.

Research investment strategy and portfolio focus

ALS Northwest framed its 2025 approach as a scaled-up commitment to research designed to accelerate innovation in amyotrophic lateral sclerosis (ALS). The organization said its efforts span multiple stages of scientific discovery, with an emphasis on enabling new approaches that could move the field forward. For research stakeholders, the operational question is not only how much is invested, but how efficiently funding is converted into validated findings, new targets, and ultimately clinical progress.

SHERIDAN, WYOMING - December 27, 2025 - United Airlines has rolled out a new set of mobile app capabilities designed to reduce airport friction, improve real-time transparency, and shift more travel support into self-service workflows during peak travel demand.

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber is sharpening its focus on electric-vehicle OEM business in the automotive & mobility sector, confirming that its GEOLANDAR X-CV highway terrain tire is now factory-equipped on the newly updated Lexus RZ battery-electric SUV for the North American market. The 235/50R20 100V fitment positions Yokohama's SUV-focused GEOLANDAR line squarely in the premium BEV arena, supporting automakers' push for quieter, more efficient and more durable EV drivetrains.

Premium EV SUV fitment strengthens North American footprint

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber is leveraging the global reach of the Gymkhana stunt-film franchise to spotlight its ADVAN flagship performance tires, with the latest episode "Gymkhana: Aussie Shred" showcasing ADVAN-equipped Subaru machinery and racking up more than 5.3 million views in its first week online.

ADVAN brand visibility in a high-impact global stunt platform

The new film, released on Hoonigan Media Machine's official YouTube channel on December 9, 2025, is the third consecutive Gymkhana installment to feature ADVAN tires as original equipment on the lead vehicle.
Co-produced by Hoonigan Media Machine, 321 Action Action and Subaru Motorsports USA, the series has become a global benchmark for extreme driving content, delivering sustained visibility for tire and performance brands among highly engaged enthusiasts.

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber is deepening its sustainability strategy and raw materials risk management by supporting an international joint research project in Indonesia aimed at preventing rubber tree leaf fall diseases, a growing threat to global natural rubber production and the tire industry's long-term resilience.

Securing Natural Rubber at the Source in Indonesia

The company is cooperating in the multi-year project "Development of Complex Technologies for Prevention and Control of Rubber Tree Leaf Fall Diseases," which targets one of the most serious plant health challenges facing natural rubber plantations in Indonesia, the world's second-largest producer.
Leaf fall disease has become widespread in key growing regions, leading to significant yield losses and jeopardizing supply for industrial users, including tire manufacturers.

SHERIDAN, WYOMING - December 26, 2025 - Yokohama Rubber has expanded its presence in the electric vehicle supply chain as Nissan chooses the AVID GT as original equipment for the new Nissan LEAF in the United States, underlining the growing role of EV-optimized tire technology in improving range, comfort and safety for mainstream electric cars.

EV-Optimized Tires for a Core Mass-Market Electric Vehicle

Yokohama Rubber has begun supplying its AVID GT in size 215/55R18 95H as factory equipment for the latest Nissan LEAF EV launched in the U.S. market in 2025. Positioned as a key electric model for drivers transitioning from internal combustion engines to battery-electric vehicles, the new LEAF benefits from a tire package specifically engineered to support higher curb weights, instant torque and demanding efficiency targets.